Senior insider sale
Chief Medical Officer at ZENTALIS PHARMACEUTICALS, INC. — senior position signals high conviction
$23.8K
2.06K shares
What this filing means
BROWNSTEIN CARRIE plans to sell 2.06K shares of ZENTALIS PHARMACEUTICALS, INC. valued at approximately $23.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2024ACC: 0001725160-24-000022
Officer· Chief Medical Officer
Since Oct 2022
2.06K
Shares to sell
$23.8K
Approx. market value
2.06K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Release
NA
2/1/2024
2.06KTotal acquired2.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/1/2024 | Restricted Stock Unit Release NA | 2.06K | — |
| Total | 2.06K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.06K
Market value
$23.8K
2/2/2024
Total
Units
2.06K
Value
$23.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/2/2024 | 2.06K | $23.8K | NASDAQ | Planned |
| Total | 2.06K | $23.8K | ||